EP
The startup operates a biotech platform that utilizes a patented exosome-based drug delivery system to target cancer stem cells, minimizing the toxic effects of chemotherapy. This approach enhances treatment efficacy for cancer patients by delivering therapies directly to affected cells, thereby reducing side effects and improving overall outcomes.
Updated 8 months ago
Funding
$358.3K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
BFounders
Product
Features
- The startup operates a biotech platform that utilizes a patented exosome-based drug delivery system to target cancer stem cells, minimizing the toxic effects of chemotherapy. This approach enhances treatment efficacy for cancer patients by delivering therapies directly to affected cells, thereby reducing side effects and improving overall outcomes.